Craig John Thompson

Affiliations

  • Director at Esperion Therapeutics Inc. (ESPR), 2025-07-02
  • President & Ceo at Anthera Pharmaceuticals Inc (ANTH), 2018-01-09
  • Chief Operating Officer at Tetraphase Pharmaceuticals Inc (TTPH), 2015-09-11
  • Chief Commercial Officer at Trius Therapeutics Inc (TSRX), 2013-09-13
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ANTH $1.32 8,550 $11,286.00 19,848 2017-09-20 Filing
ANTH $1.43 10,400 $14,892.80 11,298 2017-09-07 Filing
TSRX $6.48 133 $861.84 133 2011-08-22 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TTPH $44.08 10,000 $440,800.00 343 2015-09-08 Filing
TTPH $46.31 10,000 $463,100.00 343 2015-08-05 Filing
TTPH $47.91 10,000 $479,100.00 343 2015-07-06 Filing
TTPH $41.51 10,000 $415,100.00 343 2015-06-15 Filing
TTPH $43.00 10,637 $457,391.00 343 2015-06-08 Filing